Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors
- Conditions
- Outcomes of Trabeculectomy With MMC
- Registration Number
- NCT03293251
- Lead Sponsor
- Assiut University
- Brief Summary
1. determine whether cataract surgery has a major effect on outcomes of trabeculectomy with MMC or not.
2. Success rates of trabeculectomy with MMC in Queen Elizabeth hospital.
3. recurrence rate of uveitis after glaucoma surgery
- Detailed Description
1. determine different success rates of trabeculectomy with MMC undergone in QE hospital, UK.
2. determine different complications and effect of cataract surgery on the outcome of glaucoma surgery
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
- Fesh trabeculectomy surgeries
Exclusion Criteria
- recurrent surgeries
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Success rates 5 year period IOP less 21 mmHg
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie trabeculectomy with MMC efficacy in uveitic glaucoma and POAG?
How does trabeculectomy with MMC compare to standard-of-care glaucoma treatments in terms of success rates and complications?
Which biomarkers are associated with predicting success or recurrence after trabeculectomy with MMC in uveitic glaucoma patients?
What are the potential adverse events of trabeculectomy with MMC and I stent in uveitic glaucoma and POAG, and how are they managed?
Are there combination approaches or alternative drugs that enhance trabeculectomy outcomes in uveitic glaucoma compared to MMC alone?
Trial Locations
- Locations (1)
Maha Said
🇪🇬Egypt, Assiut, Egypt
Maha Said🇪🇬Egypt, Assiut, Egypt